检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:蒲万霞[1] 宋秉生[1] 戴凤菊[1] 董鹏程[1] 邓海平[1] 倪春霞[1] 杨志强[1]
机构地区:[1]中国农业科学院兰州畜牧与兽药研究所新兽药工程重点开放实验室,甘肃兰州730050
出 处:《贵州农业科学》2009年第10期124-126,共3页Guizhou Agricultural Sciences
基 金:中央级公益性科研院所基本科研业务费专项资金项目"断奶安对仔猪腹泻防治作用及机理研究"(BRF060303)
摘 要:小鼠口服不同剂量断奶安14~18h后分别经腹腔和静脉感染大肠埃希氏杆菌O1和O2,结果断奶安组腹腔感染大肠埃希氏杆菌O1的小鼠存活率达60%(对照组存活率10%),腹腔感染大肠埃希氏杆菌O2的小鼠的存活率为50%(对照组全部死亡);静脉感染大肠埃希氏杆菌O1的小鼠存活率达90%(对照组存活率为30%),静脉感染大肠埃希氏杆菌O2的小鼠存活率达60%(对照组存活率为10%)。小鼠经腹腔分别感染金黄色葡萄球菌(2×10^7CFU/20g)和大肠埃希氏杆菌O1(5×10^7CFU/20g)后,口服断奶安进行治疗试验,结果金黄色葡萄球菌感染组灌服断奶安100mg/kg、1000mg/kg、2000mg/kg、3000mg/kg和蒸馏水后,存活率分别为40%、70%、70%、80%和0;大肠埃希氏杆菌感染组分别灌服1000mg/kg、1500mg/k,2000mg/kg断奶安和蒸馏水后,存活率分别为40%、60%、50%和10%。表明,断奶安具有一定的免疫增强作用。Mice were infected with E. coli 01 and 02 respectively by both intravenous injection and intraperitoneal injection after orally administrated duannaian 14 - 18h. The survival rates of duannaian group with intraperitoneal injection were 60 % (control group was 10%) and 50% (control group was zero) respectively. The survival rates of duannaian group with intravenous injection were 90% (control group was 30%) and 60% (control group was 10%) respectively. Therapeutic effects of duannaian were investigated in mice which were orally administrated duannaian after abdominal infected with Staphyloccocus aureus and E. coli 01 respectively. The result showed that the survival rates of duannaian group 100 mg/kg, 1000 mg/kg, 2 000 mg/kg, 3 000 mg/kg and distilled water group were 40%, 70%, 70%, 80% and 0 respectively after infected with Staphyloccocus aureus. As for the groups in which mice were infected with E. coli 01, the result indicated that the survival rates of duannaian group 1000mg/kg, 1500mg/kg, 2000mg/kg and distilled water group were 40%, 60%, 50% and 10% respectively. Therefore,duannaian can enhance immune function.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.13